 
<prompt> Trends in IPTp use by pregnant women | Percentage of women with a live birth in the 2 years before the survey who received at least 1, 2, or 3 doses of SP/Fansidar | (IPTp1+, 2004-05 TDHS, 53) (IPTp2+, 2004-05 TDHS, 22) (IPTp3+, 2004-05 TDHS, 3) (IPTp1+, 2007-08 THMIS, 59) (IPTp2+, 2007-08 THMIS, 31) (IPTp3+, 2007-08 THMIS, 7) (IPTp1+, 2010 TDHS, 63) (IPTp2+, 2010 TDHS, 27) (IPTp3+, 2010 TDHS, 3) (IPTp1+, 2011-12 THMIS, 63) (IPTp2+, 2011-12 THMIS, 33) (IPTp3+, 2011-12 THMIS, 4) (IPTp1+, 2015-16 TDHS-MIS, 69) (IPTp2+, 2015-16 TDHS-MIS, 35) (IPTp3+, 2015-16 TDHS-MIS, 8) (IPTp1+, 2017 TMIS, 83) (IPTp2+, 2017 TMIS, 56) (IPTp3+, 2017 TMIS, 26) <response> The percentage of women receiving IPTp1+ increased from 53% in the 2004-05 TDHS to 83% in the 2017 TMIS, the percentage receiving IPTp2+ increased from 22% to 56% between these surveys, and the percentage receiving IPTp3+ increased from 3% to 26% between the 2 surveys.  